{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:37:18Z","timestamp":1791308238034,"version":"4.3.1"},"reference-count":101,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,9,20]]},"abstract":"<jats:p>Isavuconazole is the newest of the clinically available advanced generation triazole antifungals and is active against a variety of yeasts, molds, and dimorphic fungi. Its current FDA-approved indications include the management of invasive aspergillosis as well as mucormycosis, though the latter indication is supported by limited clinical data.<\/jats:p>","DOI":"10.1128\/aac.00177-22","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:00:53Z","timestamp":1660568453000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":92,"title":["New Perspectives on Antimicrobial Agents: Isavuconazole"],"prefix":"10.1128","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3375-2199","authenticated-orcid":true,"suffix":"II","given":"James S.","family":"Lewis","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Oregon Health &amp; Science University, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-5122","authenticated-orcid":true,"given":"Nathan P.","family":"Wiederhold","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Hakki","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Oregon Health &amp; Science University, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-5750","authenticated-orcid":true,"suffix":"III","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California, USA"},{"name":"Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","unstructured":"Anonymous. 2021. Full prescribing information isavuconazonium sulfate (Cresemba). United States Food and Drug Administration."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04569-14"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02942-15"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz050"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myab035"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myz103"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.037"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz188"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof6020090"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa022"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir969"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00232-5"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01354-13"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01355-13"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw098"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-010-9324-3"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01216-08"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04055-14"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00685-10"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01217-06"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.02.007"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02031-20"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02195-19"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02242-21"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz568"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01647-12"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01230-18"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00280-22"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02478-15"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt397"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku259"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01512-07"},{"key":"e_1_3_1_34_2","volume-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antifungal susceptibility testing of filamentous fungi, 2nd ed. (CLSI supplement M61). Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_1_35_2","unstructured":"EUCAST. 2020. The European Committee on Antimicrobial Susceptibility Testing: breakpoint tables for interpretation of MICs for antifungal agents version 10.0. EUCAST Copenhagen Denmark."},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.06.001"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.08.017"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00854-09"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00383-13"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa230"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01634-18"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00073-19"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05910-11"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa351"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00036-09"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01230-21"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01919-15"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00653-19"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040271"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.660347"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802562969"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01886-17"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02344-20"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2019.01.005"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx130"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw305"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010954803886"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12887"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy827"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066906"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00071-2"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00191-2"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02232-18"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003017"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx241"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.03.017"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2018.02.013"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky286"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061098"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy406"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz282"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa358"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.02.009"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2020.10.003"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa652"},{"key":"e_1_3_1_83_2","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1016\/S0924-8579(07)71514-5","article-title":"QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimens of isavuconazole","volume":"29","author":"Heep M","year":"2007","unstructured":"Heep M, Roos B, Sochor M, Schmitt-Hoffmann A, Van Merle S, Kappers D, Voiriot P. 2007. QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimens of isavuconazole. Int J Antimicrobial Agents 29:S474.","journal-title":"Int J Antimicrobial Agents"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.620"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1086\/511685"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq188"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105605"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz741"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00189"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00760-17"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/524669"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01489-16"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12452"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12339"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx228"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa274"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211029046"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00054-16"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof7020076"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12751"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00646-08"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02343-20"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00177-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00177-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T13:12:33Z","timestamp":1663679553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00177-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,20]]}},"alternative-id":["10.1128\/aac.00177-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.00177-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"2022-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00177-22"}}